Latest Takeda Pharmaceutical Company Stories
ZURICH, March 18, 2014 /PRNewswire/ -- Takeda Pharmaceuticals International GmbH ("Takeda") today announced that Giles Platford has been appointed Head of Commercial Operations,
A new study published in the British Journal of Clinical Pharmacology, recommends prescribers limit pioglitazone (Actos) use to shorter durations due to significantly increased risk of bladder
National network of attorneys continues to provide no-cost consultations over allegations that the use of the diabetes medication Actos can cause bladder cancer. San
Takeda will advance the CEOi's goal of building global momentum behind the G8's 2025 commitments WASHINGTON, Feb.
National network of attorneys is providing consumer updates and no-cost consultations over allegations that the use of the diabetes medication Actos can cause patients to develop bladder cancer.
On January 27, a federal Judge ruled that Takeda acted in “bad faith” and destroyed relevant evidence to the Actos Multidistrict Litigation.
The Firm is filing Actos lawsuits on behalf of individuals who took Actos for an extended period of time, and allegedly developed bladder cancer due to their use of the Type 2 diabetes medication.
Schlichter, Bogard & Denton, LLP is investigating and pursuing claims on behalf of individuals who allege that they have been diagnosed with bladder cancer after taking the diabetes medication
The Firm is representing clients in Actos lawsuits that allege long-term use of the Type 2 diabetes drug caused bladder cancer. New Yor, New York (PRWEB) January
Flood Law Group to Review Claims on Behalf of People Who Have Taken Actos and Also Had Bladder Cancer Washington, DC (PRWEB) January 24, 2014 With bellwether
- A serpent whose bite was fabled to produce intense thirst.